Treatment Landscape of Extensive Stage SCLC: Overview and Lurbinectedin - 2024 Lung Cancer OncTalkvia @YouTube 

In this video, Dr. Shields discusses the overall landscape of treatment for Extensive Stage Small Cell Lung Cancer (ES-SCLC) including chemoimmunotherapy. She also discusses the treatment of relapsed/recurring Extensive Stage Small Cell Lung Cancer and FDA drug approvals such as Lurbinectedin and Atezolizumab.   

For more, please visitTo join the conversation, visit